Liver transplantation as a treatment option for three siblings with homozygous familial hypercholesterolemia

Pediatric Transplantation

Volumn 15, Issue 3, 2011, Pages 281-284

  Küçükkartallar, Tevfik ^a,b   Yucel, Yankol ^a   Turan, Kanmaz ^a   Topaloǧlu, Serdar ^a   Koray, Acarli ^a   Munci, Kalayoglu ^a  

^a MEMORIAL HOSPITAL   (Turkey)

^b Memorial Hospital   (Turkey)

Author keywords

familial hypercholesterolemia; liver transplantation; siblings; surgical treatment

Indexed keywords

EZETIMIBE; FLUINDOSTATIN; MARINCAP; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEGA 3 FATTY ACID; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CASE REPORT; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; SIBLING;

ADOLESCENT; CHILD; CHOLESTEROL; CHOLESTEROL, LDL; FAMILY HEALTH; FEMALE; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPIDS; LIVER; LIVER TRANSPLANTATION; MALE; MUTATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955000769     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01469.x     Document Type: Article

References (23)

1. Bilheimer DW, Goldstein JL, Grundy SM, et al., Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984: 311: 1658-1664. (Pubitemid 15183996)
2. Goldstein JL, Brown MS,. Familial hypercholesterolemia. In:, Scriver CR, Beaudet AL, Sly WS, et al., eds. The Metabolic Basis of Inherited Disease, vol 1, edn 6. New York, NY: McGraw-Hill, 1989: pp. 1215-1250.
3. Scott HW Jr,. Ileal bypass in the control of hyperlipidemia and atherosclerosis. Arch Surg 1978: 113: 62-70. (Pubitemid 8274505)
4. Starzl TE, Putnam CW, Chase HP, et al., Portocaval shunt in hyperlipoproteinaemia. Lancet 1973: 2: 940-944.
5. Starzl TE, Demetris AJ, Van Thiel D,. Liver transplantation (first of two parts). N Engl J Med 1989: 321: 1014-1022. (Pubitemid 19253416)
6. Marais AD,. Familial hypercholesterolemia. Clin Biochem Rev 2004: 25: 49-68.
7. Rader DJ, Cohen J, Hobbs HH,. Monogenic hypercholesterolemia: New insights in pathogenesis and treatment. J Clin Invest 2003: 111: 1795-1803. (Pubitemid 38057721)
8. Sibley C, Stone NJ,. Familial hypercholesterolemia: A challenge of diagnosis and therapy. Cleve Clin J Med 2006: 73: 57-64.
9. Gagne C, Gaudet D, Bruckert E,. Ezetimibe Study Group. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 2002: 105: 2469-2475. (Pubitemid 34568966)
10. Thompson GR,. LDL apheresis. Atherosclerosis 2003: 167: 1-13. (Pubitemid 36258395)
11. Lopez-Santamaria M, Migliazza L, Gamez M, et al., Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass. J Pediatr Surg 2000: 35: 630-633. (Pubitemid 30181048)
12. Bilheimer DW, Goldstein JL, Grundy SM, et al., Reduction in cholesterol and low density lipoprotein synthesis after portocaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest 1975: 56: 1420-1430.
13. Valdivielso P, Escolar JL, Cuervas-Mons V, Pulpõn LA, Chaparro MA, González-Santos P,. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia. Ann Intern Med 1988: 108: 204-206. (Pubitemid 18081194)
14. Barbir M, Khaghani A, Kehely A, et al., Normal levels of lipoproteins including lipoprotein(a) after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia. Q J Med 1992: 85: 807-812. (Pubitemid 23012373)
15. Offstad J, Schrumpf E, Geiran O, Søreide O, Simonsen S,. Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia. Clin Transplant 2001: 15: 432-436. (Pubitemid 33094996)
16. Popescu I, Simionescu M, Tulbure D, et al., Homozygous familial hypercholesterolemia: Specific indication for domino liver transplantation. Transplantation, 2003: 6: 1345-1350. (Pubitemid 37430722)
17. Schmidt HH, Tietge UJ, Buettner J, et al., Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation. Transpl Proc 2005: 37: 2250-2252.
18. Kakaei F, Nikeghbalian S, Kazemi K, et al., Liver transplantation for homozygous familial hypercholesterolemia: Two case reports. Transpl Proc 2009: 41: 2939-2941.
19. Ahualli L, Stewart-Harris A, Bastianelli G, et al., Combined cardiohepatic transplantation due to severe heterozygous familial hypercholesteremia type II: First case in Argentina-A case report. Transplant Proc 2007: 39: 2449-2453. (Pubitemid 47418215)
20. East C, Grundy S, Bilheimer DW,. Normal cholesterol levels with lovastatin (Mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation. JAMA 1986: 256: 2843-2848. (Pubitemid 17178363)
21. Alkofer BJ, Chiche L, Khayat A, et al., Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: Report of the first case and review of the literature. Transpl Proc 2005: 37: 2250-2252. (Pubitemid 40956423)
22. Kawagishi N, Satoh K, Akamatsu Y, et al., Long-term outcome after living donor liver transplantation for two cases of homozygous Familial Hypercholesteremia from a heterozygous donor. J Atheroscler Thromb 2007: 14: 94-98.
23. Starzl TE, Bahnson HT, Hardesty RL, et al., Heart-liver transplantation in a patient with familial hypercholesterolemia. Lancet 1984: 1: 1382-1383. (Pubitemid 14122021)